Invenomic Capital Management’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-153,463
Closed -$9.11M 142
2026
Q1
$9.11M Sell
153,463
-8,244
-5% -$398K 0.42% 74
2025
Q4
$6.34M Buy
161,707
+375
+0.2% +$14.5K 0.3% 101
2025
Q3
$6.51M Sell
161,332
-11,136
-6% -$454K 0.32% 88
2025
Q2
$6.56M Sell
172,468
-467,131
-73% -$17.1M 0.37% 84
2025
Q1
$27.4M Sell
639,599
-26,072
-4% -$1.11M 1.38% 18
2024
Q4
$27M Sell
665,671
-101,414
-13% -$4.22M 1.28% 18
2024
Q3
$29.4M Sell
767,085
-23,332
-3% -$1.01M 1.61% 15
2024
Q2
$37M Buy
790,417
+35,248
+5% +$1.77M 1.8% 12
2024
Q1
$39.2M Buy
755,169
+210,451
+39% +$9.58M 2.08% 9
2023
Q4
$23.9M Buy
544,718
+239,610
+79% +$10.9M 1.09% 27
2023
Q3
$14.5M Buy
305,108
+8,235
+3% +$373K 0.61% 55
2023
Q2
$11.3M Buy
+296,873
New +$10.7M 0.57% 51
2022
Q3
Sell
-249,216
Closed -$11M 180
2022
Q2
$11M Buy
249,216
+70,709
+40% +$3.64M 0.78% 44
2022
Q1
$9.65M Sell
178,507
-15,534
-8% -$669K 1.03% 29
2021
Q4
$6.54M Buy
194,041
+98,387
+103% +$3.51M 1.4% 19
2021
Q3
$3.15M Buy
95,654
+38,669
+68% +$1.07M 1.02% 35
2021
Q2
$1.79M Buy
+56,985
New +$1.53M 0.43% 46
2020
Q3
Sell
-51,293
Closed -$490K 173
2020
Q2
$490K Buy
+51,293
New +$358K 0.36% 82

Other funds holding OVV

Invenomic Capital Management's OVV Position: Q2 2026 in Review

Invenomic Capital Management sold out of Ovintiv (OVV) in Q2 2026, closing a stake of 153,463 shares — an estimated $9.11M sold.

Invenomic Capital Management first reported a position in OVV in Q2 2020 and held it in 18 quarters. The position peaked at $39.2M in Q1 2024. 593 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • Invenomic Capital Management reported no remaining Ovintiv position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 153,463 Ovintiv shares in Q2 2026, an estimated $9.11M.
  • Invenomic Capital Management first reported a position in Ovintiv in Q2 2020 and held it in 18 quarters.
  • Invenomic Capital Management's Ovintiv position peaked at $39.2M in Q1 2024.
  • 593 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.